All Activity
- Yesterday
-
Marijuana Moment: Congress Holds Hearing On Psychedelics’ Medical Benefits For Military Veterans
Tokeativity posted a topic in Marijuana Moment
A congressional committee held a hearing about increasing military veterans’ access to psychedelic treatments—with officials from the U.S. Department of Veterans Affairs (VA) testifying alongside medical professionals and researchers. The hearing—titled “Psychedelic-Assisted Therapies for Veterans: The Path Forward”—was held before the House Veterans’ Affairs Subcommittee on Health on Wednesday. Rep. Mariannette Miller-Meeks (R-IA), chair of the panel, began the hearing by noting that “emerging research into substances such as MDMA and psilocybin has shown promise for treating PTSD, treatment-resistant depression, and other serious mental health conditions.” “While more research is needed, these developments should at least give us a reason to be optimistic,” she said. “Fortunately, the VA is uniquely positioned to help lead this effort. With one of the largest integrative healthcare systems in the country, a robust research enterprise and decades of experience treating veterans with complex mental health conditions, the VA has the capabilities to help move these therapies from research toward clinical practice.” The congresswoman, who is a physician, noted that she never imagined herself supporting psychedelic therapy when she entered Congress in 2021, but said after “meeting with veterans from all walks of life, I have found the effectiveness of these treatments and am willing to advance it as potential hope.” “If these emerging therapies can help improve outcomes, restore hope, and save lives, then we owe it to our veterans to responsibly pursue this opportunity,” Miller-Meeks said. “They have earned nothing less.” Rep. Julia Brownley (D-CA), the Democratic ranking member on the subcommittee, noted that the hearing comes at “a very pivotal moment for veterans and lawmakers interested in psychedelic-assisted treatments.” “We are on the cusp of seeing [Food and Drug Administration] approval for psychedelic compound to treat mental health conditions at a time when we have not seen a novel treatment approved for mental health conditions for many years,” she said. “This is extremely welcome news and will change lives for the better. Brownley cautioned, however, that psychedelics, like other treatments, “will not be a panacea for everyone, and particularly not for every veteran.” “It’s also important that VA is ready to contend with the growth in private sector providers that will inevitably occur in response to the massive demand for psychedelics once these drugs receive FDA approval,” she said. “As we have already seen with other treatments, such as ketamine being prescribed off-label for depression, the entry of psychedelics to the market will likely lead to growth in the industry of wellness centers centers marketing themselves to veterans. It will be critical for VA to carefully develop criteria for any provider of psychedelic-assisted treatments to be able to join its community care network.” Andrew Gradison, a senior advisor to the under secretary for health at the VA’s Veterans Health Administration (VHA), said in testimony for the hearing that President Donald Trump’s administration “has taken decisive action to accelerate psychedelic research and eliminate regulatory obstacles that have historically slowed progress.” He cited an executive order Trump signed in April with the aim of expediting psychedelic therapy access, saying it was the “first EO in American history dedicated specifically to accelerating clinical research and regulatory review of psychedelics, underscoring the president’s firm commitment to advancing emerging treatments for serious mental illnesses.” Since then, “VA’s psychedelics research portfolio has grown substantially in response, and our interagency partnerships are driving rapid and safe scientific advancement,” Gradison said, noting that it is now conducting 21 active clinical studies on psychedelics to treat mental health conditions. He specifically cited a clinical trial VA announced in August to investigate whether psilocybin can help military veterans who are struggling with treatment-resistant depression. WATCH "This is very helpful, especially for the wounds of war that are sometimes not seen, as we know with PTSD. I am glad to see that we are leading the effort, and this is what the American people demand." Congressman Hamadeh’s Opening Remarks at today’s @HouseVetAffairs… pic.twitter.com/omv88q2NQi — Office of Congressman Abe Hamadeh (@RepAbeHamadeh) November 18, 2026 “VA strives to lead the Nation in exploring the therapeutic potential of psychedelic drugs,” Gradison said, adding that the department recognizes that substances such as psilocybin, MDMA and ibogaine “offer promising potential for the complex mental health conditions affecting many of the Veterans we treat.” The VA official also touted a memorandum of understanding his department signed with the Department of Health and Human Services (HHS) in July outlining a partnership to collaborate on research and development of psychedelic medicines to treat people struggling with serious mental health conditions. The agreement, he said “lays the groundwork for unprecedented VA-HHS operational cooperation on psychedelic trials.” “As we prepare for potential clinical implementation, VA remains anchored in three core priorities: first, ensuring Veteran safety above all else; second, building a rigorous body of evidence to determine which treatments work for which Veterans; and third, laying the foundation so that, pending all regulatory approvals, VA is positioned to be the first health care system in the Nation to deliver these treatments to Veterans. These priorities shape every research, clinical, and policy decision we make in this space.” Gradison said VA has already identified 10 facilities “with the expertise, physical space, and operational capacity needed to serve as early implementers, educators, or sites-in-training” with teams that are “experienced in psychedelic research protocols and are preparing to translate that experience into clinical care that maximizes Veterans’ safety if treatments are approved.” The VA official emphasized, however, that the department discourages self-medicating with psychedelics or using them to replace other mental health treatment options. The post Congress Holds Hearing On Psychedelics’ Medical Benefits For Military Veterans appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net -
“There are Republican senators who believe in cannabis law reform, and it remains to be seen what the environment in the Senate is going to be.” By Stephen Simpson, The Texas Tribune Sarah Todd, director of the Texas Cannabis Policy Center, felt confident that James Talarico would win his U.S. Senate seat on election night, but when she witnessed a complete blue wave wash over the state, she felt something else: optimism for an adult-use cannabis market in the Lone Star State. “I’m very surprised and now very excited for this new day in Texas,” Todd said. “I think we have a very clear path to adult legalization in Texas.” Lawmakers last week filed a slew of proposals ahead of the legislative session that starts in January, including several that would legalize, tax and regulate marijuana in Texas. Adult-use cannabis bills have been submitted by lawmakers for the past several legislative sessions, but Republican-dominated health committees and the Senate often squashed them before they got far. Todd said this is due to soon-to-be former Lt. Gov. Dan Patrick, who made it a priority to ban THC products last legislative session. But with new THC-friendly leadership being established in multiple state positions, the concept of legalizing marijuana has never been closer to a reality, Todd said. “There are Republican senators who believe in cannabis law reform, and it remains to be seen what the environment in the Senate is going to be,” she said. “But I’m very hopeful and positive that we’re going to be having a lot different conversations than we’ve ever had in the past.” If an adult-use cannabis program is approved in Texas, it will join a growing list of states that have created entire industries off a plant, but what that might mean for the current THC market in the state still needs to be figured out. “Part of what we are working on is making sure that all stakeholders have a voice in this process,” Todd said. The THC market in Texas The legal THC market in Texas is almost entirely hemp-derived products sold by licensed retailers. The only legal marijuana available to the public is the Texas Compassionate Use Program, which is meant for patients who meet specific medical conditions. Hemp and marijuana are pretty much the same thing, coming from the same plant, with the real distinction between the two being how much THC it contains when harvested. Under the 2018 federal Farm Bill, hemp with no more than 0.3 percent delta-9 THC became legal nationwide, leading to a booming industry in Texas with farmers, distributors and stores quickly taking advantage of the rule change to sell legal high-inducing products to the public. The Texas Department of State Health Services lists about 14,000 retail stores licensed to sell consumable hemp, with the industry generating around $300 million a year in state tax revenue. Over the past year, state rules and court rulings have narrowed the hemp market sharply, and a looming federal ban coming next month is putting more pressure on the shrinking legal THC market in Texas. DSHS earlier this year passed new rules on the hemp industry enforcing a 0.3 percent total THC limit that eliminates smokable hemp, which makes up more than half of some stores’ inventory. A federal funding deal will also ban hemp-derived products with more than 0.4 milligrams of THC, criminalizing nearly all consumable hemp nationwide and effectively shutting down the $8 billion industry in Texas. Lukas Gilkey, chief executive of Hometown Hero, a manufacturer of hemp-derived products, said industry leaders plan to speak with lawmakers to discuss market protections and clarity on their future. “We’re going to start working with lawmakers to repeal all of this nonsense immediately,” he said about the state rules. However, some drug policy experts say that, due to the growing number of restrictions, it might be easier to bring an adult-use cannabis market forward to avoid clashing with the federal government over hemp. “Texas could also consider creating a more comprehensive legal cannabis market, as 24 other states have done, and allow smokable cannabis through that channel,” Katharine Neill Harris, a drug policy fellow at Rice University’s Baker Institute for Public Policy, previously said. Todd said part of her organization’s goal is to ensure hemp distributors, farmers and store owners are brought into the fold of the adult-use cannabis market or allowed to work in tandem with it. “None of these early-filed bills had any language to indicate how lawmakers were thinking about handling the existing hemp THC market,” Todd said. “We had some meetings with the lawmakers that filed the bills to make sure that’s on their radar to ensure this is handled in a thoughtful way to allow these small-business owners who employ over 50,000 people in Texas to continue to operate.” In the past, medical cannabis license holders have often clashed with the hemp industry due to what they viewed as unfair state regulations being placed on them when a similar plant was being sold unchecked. However, the medical cannabis program has seen some of these restrictions slowly rolled back, and Nico Richardson, CEO of Texas Original, said the midterm election results create an opportunity to expand the Texas Compassionate Use Program and improve patient access even further. “We are grateful for the support of leaders on both sides of the aisle who have helped more Texans access the medicine they need,” he said. “As we approach the 2027 legislative session, strong safety standards for all THC products and expanded access to well-regulated medical cannabis should remain priorities.” Jervonne Singletary, a spokesperson for the Austin medical marijuana company goodblend, said her company has always believed that Texans deserve safe, reliable access to cannabis, whether as a patient or as an adult, but some questions need to be answered first. “Who will test these products and make sure consumers can trust what is on the label? What standards will apply to how cannabis is grown and manufactured? What products should be available? What rules make sense around packaging and advertising? And just as importantly, how do we make sure patients continue to have a medical program that works for them?” she said in an emailed statement. Singletary said the medical cannabis community welcomes the conversation around adult-use cannabis, but legalization is only part of the conversation. “Texas also has to make sure the right infrastructure is in place to support it,” she said. “At the end of the day, people access cannabis for a myriad of reasons, and we should respect those choices. There is room for a strong medical program and a responsible adult-use market to exist side by side.” Todd agreed, saying she believes medical cannabis, adult-use marijuana and hemp-derived products can all coexist because each person might want different items or products despite it coming essentially from the same plant. “I know in Minnesota they have put in place some regulations that allow their adult-use retailers and license holders to continue selling cannabis, and then you get lower-potency hemp-derived products over the counter and then a separate higher-strength medical cannabis program,” she said. How would legal cannabis work? Two bills filed by Reps. Joe Moody, D-El Paso, and John Bucy, D-Austin, both titled the Texas Regulation of Cannabis Act, would let adults 21 and older possess 2 ounces of cannabis, including up to 15 grams of concentrate. The bills would also allow adults to grow up to 12 plants at home, and local governments couldn’t ban or unreasonably restrict marijuana businesses. The Texas Department of Licensing and Regulation would oversee the market. Retail sales would carry a 20 percent tax on top of sales tax, and grower-to-retailer sales a separate 15 percent tax. Tax revenues would fund public schools, veterans assistance programs, chemical dependency prevention, treatment and rehab services and local governments for regulation and oversight. A bill filed by Sen. Carol Alvarado, D-Houston, similarly set rules, regulations and protections for cannabis users and distributors. Todd said while these bills are a great start, there are many things that still need to be discussed before adult-use cannabis is ready to be established in Texas, even if it does receive approval from lawmakers and Gov.-elect Gina Hinojosa. “First and foremost, I think it’s imperative to pass some decriminalization along with legalizing for adults,” she said. “Decriminalization of low-level possession has been a priority of ours for a long time.” Several years ago, five Texas cities voted to decriminalize having small amounts of marijuana, but Republican Attorney General Ken Paxton sued them to block their ordinances from going into effect. Todd said that with Paxton being replaced by Democrat Nathan Johnson, who has supported decriminalization in the past, next year is a prime opportunity to take this effort statewide and safely establish the adult-use cannabis market. “Decriminalization passed the House last session, and we really had good traction before it died in the Senate, like it does every time. I believe that we can really get it passed this time around and it will happen in tandem with an adult-use bill,” she said. Todd said one benefit of the hemp markets’ rise in Texas over the past several years is that it creates a blueprint for lawmakers to use to create an adult-use marijuana industry. She said hemp-derived products prove the demand is there; now it’s important to ensure a legal marijuana market is done correctly. “We don’t want this to look like other states,” Todd said, who has previously criticized the bills Moody and Bucy proposed as too much of a tax burden on retailers and growers. “I think every other state that’s gone before us has made some pretty serious mistakes that have really hampered retail, specifically with overtaxation and overregulation.” Even if lawmakers approve legal cannabis, it may take a couple of years to establish in Texas because the state must go through the rulemaking process, distribute licenses, and build facilities. Todd said that while there is still a long way to go before an adult-use marijuana market is established in Texas, she is feeling positive and hopeful about the future for the first time. “I think that we have a real chance of getting the plant to the people,” she said. “We have a really big opportunity here in Texas to do it a little bit differently and to do it really sensibly.” This article first appeared on The Texas Tribune. The post Texas Has A ‘Clear Path’ To Legalizing Marijuana In 2027, Advocates Say, Even As Obstacles Remain appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
Local officials in Houston, Texas have officially amended the city charter to make misdemeanor marijuana possession the “lowest possible enforcement priority” for local police after voters approved the reform on the ballot this month. The initiative, which passed with more than 70 percent of the vote, was placed on the ballot after activists with Ground Game Texas submitted nearly 40,000 signatures in support of the Houston Freedom Act, which also bans no-knock warrants in the city. The City Council on Tuesday formally canvassed the results of the election and adopted the amendment to the city charter. The cannabis initiative says that its purpose was to “carefully allocating scarce city resources, reducing the risk of discriminatory enforcement practices, and focusing city resources on the highest priority public safety concerns.” “The City shall update its annual budget, police department manual, and relevant policies and procedures to ensure that public safety resources are not wasted on misdemeanor marijuana enforcement, and are instead targeted at other programs that best promote the health, safety, and general welfare of the people of Houston,” it says. The measure says the city should support diversion options such as referrals to treatment or participation in community service programs as an alternative to arrest for people accused of Class A or Class B misdemeanor marijuana possession. Officers will still be allowed to seize any substance that they have probable cause to believe is marijuana, however. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Now that the measure has been enacted, the city manager will need to ensure that budgets and reporting account for “total funds and staff time” spent on THC testing of cannabis-related substances. There will also need to be a one-time audit of all misdemeanor marijuana enforcement conducted by city police within the past five years, including a breakdown of arrests made and citations issued, with demographic breakdowns for age, gender, race and ethnicity. “To the best of their ability, the City shall determine: (a) the average total staff hours required per misdemeanor marijuana charge, including officer time, transit time, and any staff processing time; (b) the average total cost to the City per misdemeanor marijuana charge; (c ) the estimated total spent by the City on THC testing for each year under review; and (d) the estimated total spent by the City on misdemeanor marijuana enforcement, including staff and testing costs, for each year under review.” Going forward, local officials will additionally need to issue annual reports on implementation of the lowest-enforcement priority policy for cannabis possession arrests. A spokesperson for the Houston Police Department did not immediately reply to Houston Public Media’s questions about how the newly adopted charter amendment will change local law enforcement policy. Ground Game has previously organized efforts to put more far-reaching measures to decriminalize marijuana under local law on the ballot in several cities across Texas, with some passing and some failing. In general, the measures that have been approved in Austin, Denton, Elgin, Harker Heights, Killeen and San Marcos were aimed at preventing police from making arrests or issuing citations for Class A or B misdemeanor cannabis possession offenses, unless it’s part of a high priority felony investigation for narcotics or violent crime. State Attorney General Ken Paxton (R), however, has sued to block enactment of those local cannabis decriminalization laws—saying that “we don’t allow cities the ability to create anarchy by picking and choosing the laws they enforce.” Paxton lost a race for U.S. Senate to Democrat James Talarico, who supports marijuana legalization. Attorney General-elect Nathan Johnson (D) also backs legalizing cannabis. The Texas Supreme Court sided with the current outgoing attorney general in his quest to overturn the local voter-approved cannabis laws. Meanwhile in Texas, lawmakers are preparing a push to legalize marijuana in the 2027 session. State regulators have moved to ban certain hemp-derived THC cannabis products, including those containing delta-8 and delta-10 THC. Now classified as Schedule I drugs, possession is treated as a felony, carrying a punishment of 180 days to two years in prison and fines of up to $10,000. The restrictions are being challenged through litigation filed by hemp companies. The post Houston City Council Officially Makes Marijuana A Low Priority For Police After Voters Approve Ballot Measure appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
Light Waight Connect joined the community
-
Marijuana Moment: Top Oklahoma GOP Senator Files Bill To Protect Medical Marijuana Patients’ Gun Rights
Tokeativity posted a topic in Marijuana Moment
A top Oklahoma Republican senator has filed a bill for the 2027 session aimed at protecting the gun rights of medical cannabis patients under state law. The new legislation from Senate Majority Floor Leader Julie Daniels (R) would modify the state’s Self-Defense Act to ensure that applicants for handgun licenses “shall not be considered ineligible solely on the basis of being a lawful holder of a medical marijuana patient license.” If enacted, state law would specify that “nothing in this section shall be construed to allow the Oklahoma State Bureau of Investigation to deny an otherwise qualified applicant from obtaining a handgun license pursuant to the Oklahoma Self-Defense Act solely on the basis of the applicant being a lawful holder of a medical marijuana patient license.” It would, however, still be unlawful to carry or use firearms when under the influence of medical marijuana if the “current effects or aftereffects of such consumption affect mental, emotional, or physical processes to a degree that would result in abnormal behavior”—in line with existing state laws for prescription drugs. The Oklahoma Senate passed a similar medical marijuana gun rights bill from Daniels last year but it later died in a House committee without further action. The new proposal has been given the designation of SB 1, likely signaling its importance to the majority floor leader. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The latest state-level measure comes as the federal government is updating its approach to cannabis consumers’ gun rights. In April, the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) posted a draft update to gun purchase form to acknowledge the federally legal status of medical marijuana under rescheduling. In August, the Department of Justice unveiled a rule intended to help restore gun rights to people who have been barred from possessing firearms that contains provisions to block officials from denying applications over the use of marijuana or convictions for cannabis-related activity. In June, the Supreme Court issued a decision uphold the Second Amendment rights of people who use marijuana, A recent poll found that one out of four people who consume marijuana say that are more likely to purchase a gun in light of the Supreme Court’s ruling. The post Top Oklahoma GOP Senator Files Bill To Protect Medical Marijuana Patients’ Gun Rights appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net -
Wisconsin’s incoming governor says he understands that people in his state are “high on passing marijuana legally”—which he supports—but he wants to make sure that lawmakers carefully craft a plan that gets the details right rather than rushing into it. “My position hasn’t changed, but as someone who served in the Legislature, the devil’s always in the details,” Gov.-elect David Crowley (D) told The Milwaukee Courier. We’re missing out on tens of millions, if not hundreds of millions of dollars of revenue that could be funding many of the priorities that we ran on,” he said, referring to previously discussed plans to use legal cannabis taxes to offset cuts to Medicaid and to support education programs. “But I truly believe that it is time for the state of Wisconsin to legalize marijuana, and I look forward to getting that passed.” While top Democratic lawmakers have said that they want to legalize cannabis within the first year of their control of the legislature following the party’s wins in this month’s midterm elections, the governor-elect said he still has questions about “what does that timeline look like.” “I know that a lot of people are high on passing marijuana legally,” Crowley said. “I want to make sure that we’re doing it the right way, the best way for the state of Wisconsin, and we do that by talking to other states that did this by learning the dos and don’ts. I want to make sure that whatever we put in place works for everyone.” The local news outlet also asked the incoming governor is be plans to build on incumbent Gov. Tony Evers’s (D) record of granting clemency to people with past convictions. “I commend the governor on bringing commutations back to the state of Wisconsin. I think it’s extremely important how we give second chances and set up a lot of people to become better citizens, returning citizens into society,” Crowley said. “And it is something that I will continue as the next governor of this great state. I believe in criminal justice reform, and believe that we have to strengthen many of our laws as it relates to criminal justice. And look forward to working with the Legislature to do so in some capacity.” Sen. Dianne Hesselbein (D), who was elected to be Senate minority leader when the legislature convenes in January, and Rep. Greta Neubauer (D), incoming speaker of the Assembly, recently discussed their support for legalizing marijuana within their first year in control of their respective chambers. “Definitely. Yeah, without even hesitation, yes,” Hesselbein said. “Absolutely, we need to get that done.” Meanwhile, Sen. Julian Bradley (R), the incoming minority leader in his chamber, did not rule out the possibility of working with Democrats to legalize cannabis, but said he wants to see the details of their plan first. Democratic lawmakers and Evers, the outgoing governor, has pushed to legalize marijuana for recreational and medical purposes for years, but those proposals have been blocked by the legislature’s Republican majority. A limited medical cannabis bill did clear one committee this session, but did not advance further. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Democratic lawmakers filed legislation in the 2026 session to broadly legalize and regulate marijuana, and bipartisan legislation to simply decriminalize cannabis possession was also filed—but neither proposal advanced. A poll released last year by Marquette Law School found that two in three Wisconsin voters support legalizing marijuana. A legislative analysis requested by lawmakers estimated that Wisconsin residents spent more than $121 million on cannabis in Illinois alone in 2022, contributing $36 million in tax revenue to the neighboring state. Meanwhile, the state Department of Revenue released a fiscal estimate of the economic impact of a legalization bill in 2023, projecting that the reform would generate nearly $170 million annually in tax revenue. The post ‘It Is Time’ For Wisconsin To Legalize Marijuana, But It Needs To Be Done ‘The Right Way,’ New Governor Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
Two Republican senators are saying they will not support passage of any bill to keep the federal government funded if it includes language to reverse the currently scheduled recriminalization of hemp THC products. After bipartisan colleagues filed legislation on Tuesday that would replace the ban with new legal regulations to keep consumable hemp products available to adults—which industry advocates hope can be attached to larger, must-pass appropriations legislation—Sen. Ted Budd (R-NC) said he “will not support any year-end package that extends, delays, or builds a regulatory framework around products that fuel addiction, endanger our children, and weaken our workforce.” “Congress closed the hemp loophole more than a year ago to end an industry that never should have existed,” he said in a social media post. “I’ve heard from countless constituents whose loved ones’ addictions began with the very products the Sheehy-Klobuchar bill would legalize at even higher, more dangerous potency.” The new bipartisan hemp regulation bill from Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN), the Hemp Guardrails Act, would stop the ban that is scheduled to go into effect next month while instituting a set of new product rules as an alternative to prohibition. Congress closed the hemp loophole more than a year ago to end an industry that never should have existed. I've heard from countless constituents whose loved ones' addictions began with the very products the Sheehy-Klobuchar bill would legalize at even higher, more dangerous… https://t.co/flDSGXjzYe — Senator Ted Budd (@SenTedBuddNC) November 17, 2026 Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that redefined hemp to make it so only products with 0.4 milligrams of total THC per container would remain legal after November 12. Under provisions included in a separate funding bill Trump signed this September, however, the effective date of the ban for most products was pushed back to December 11 to give lawmakers more time to craft regulations for hemp derivatives. There was a carve-out, however, to allow the recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” Budd had tried unsuccessfully to get the delay language removed from the bill that Trump most recently signed. Sen. Pete Ricketts (R-NE), another outspoken opponent of cannabis reform, said on Tuesday that he agrees with Budd. “I won’t support any legislation that allows these drugs to continue hurting our kids and communities,” he said in a social media post. I’m with @SenTedBuddNC on this. I won’t support any legislation that allows these drugs to continue hurting our kids and communities. https://t.co/BmSeunhCKL — Senator Pete Ricketts (@SenatorRicketts) November 18, 2026 Meanwhile, the new legislation from Sheehy and Klobuchar would raise the legal threshold for hemp to one percent total THC on a dry-weight basis—with an exception to go above that for in-process materials—and create a new category of prohibited cannabinoids that include delta-8 THC, delta-10 THC and THC-O-acetate , while also restricting the manufacturing or synthesizing of those compounds outside of the hemp plant. The measure would continue allowing conversions for CBD, delta-9 THC and other natural hemp compounds outside of the plant, but only if it results in a naturally occurring end product. Raw floral hemp material, smokable hemp flower or hemp pre-rolls would be barred from entering interstate commerce. There would be an age limit of 21 to possess and consume hemp cannabinoid products, and they would need to be grown, processed and packaged within the U.S. to be legal. The bill also seeks to establish categories for hemp-derived products and supplements under the Federal Food, Drug, and Cosmetic Act and directs the Food and Drug Administration (FDA) to set rules for packaging, labeling, manufacturing, testing, registration and recalls within 180 days. Certain industrial hemp products not containing cannabinoids—such as seed, seed oil, and hempseed protein—would be considered food additives, subject to applicable safety requirements. The legislation preserves the authority of states to enact stricter hemp regulations but prohibits them from blocking the interstate transportation of compliant products. We’re taking a commonsense approach to this issue. My bill with @amyklobuchar will put bad actors in the hemp space out of business and keep intoxicating products away from children. It will also stop Congress from turning the farmers, veterans, and cancer patients who rely on… https://t.co/ZIe1d8NbBR — Tim Sheehy (@TimSheehyMT) November 17, 2026 Sheehy said in a social media post that the legislation takes “a commonsense approach to this issue.” The bill “will put bad actors in the hemp space out of business and keep intoxicating products away from children,” he said. “It will also stop Congress from turning the farmers, veterans, and cancer patients who rely on these products into criminals overnight.” Klobuchar, for her part, posted that the proposal will “keep safe hemp products on the market, protect kids and consumers, and ensure farmers, brewers, and small businesses can continue to operate, grow, and create jobs.” “I have strongly opposed the hemp ban that was signed into law last year,” she said. “If Congress and the White House don’t pass this safety bill or a similar measure it will have far-reaching economic consequences across the country.” I'm introducing the bipartisan Hemp Guardrails Act with Republican Sen. Sheehy to keep safe hemp products on the market, protect kids and consumers, and ensure farmers, brewers, and small businesses can continue to operate, grow, and create jobs. I have strongly opposed the hemp… — Amy Klobuchar (@amyklobuchar) November 17, 2026 Meanwhile, a top GOP congressman is pushing to attach provisions to keep hemp products legal to larger spending legislation in the coming weeks. “The best opportunity, in my opinion, is to get this on a bill that is going to pass,” Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, said. “The only bill that I think that absolutely, positively has to pass is going to be another continuing resolution, which is what got us here to begin with.” Rep. Morgan Griffith (R-VA) similarly recently floated the idea of including hemp extension and regulation language in a broader budget reconciliation bill. Miller of U.S. Hemp Roundtable said he group is looking forward to working with Sheehy and Klobuchar to secure their bill’s provisions “inclusion in the next spending bill or continuing resolution that will keep the government open for business.” The Congressional Research Service noted in a recent report that the Food and Drug Administration (FDA) is now more than nine months late in fulfilling a legal mandate to publish a list of known cannabinoids and guidance on hemp product containers that was included in last year’s hemp product recriminalization legislation. Aside from the new Senate legislation, a number of lawmakers from both chambers and both parties have filed or are circulating a growing number of bills to prevent the scheduled federal recriminalization of hemp THC drinks and other products. Comer, for example, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. Reps. Beth Van Duyne (R-TX) and Greg Landsman (D-OH) introduced a bill to keep hemp THC drinks legal while taxing and regulating them like alcohol. Separately, Reps. Andy Barr (R-KY) and Angie Craig (D-MN) filed a lengthier proposal to prevent the federal recriminalization of hemp THC products and put in place a number of regulations for manufacturing, labeling, sales and taxation of hemp-derived products, including an age limit of 21. Griffith and Rep. Marc Veasey (D-TX) introduced a measure to allow continued sales of hemp THC products to adults over 21, with new regulations, Several Republican lawmakers recently spoke to Marijuana Moment about the kinds of rules they would like to see enacted to keep hemp THC products legal. This week, Veterans of Foreign Wars and other military veterans groups sent a letter urging Congress to keep hemp THC products legal. The post GOP Senators Say They’ll Try To Block Any Government Funding Bill That Keeps Hemp THC Products Legal appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
“Alcohol manufacturers are the only tier of their own industry asking Congress to kill a category that Forbes has called a $38.5 billion industry.” By Jim Higdon, Cornbread Hemp In a new letter, alcohol manufacturers are again begging lawmakers to ban THC products made from hemp. On November 12, six trade associations led by the Beer Institute and the Distilled Spirits Council of the United States wrote to every member of Congress to declare their “unequivocal support” for the federal ban on hemp products containing more than 0.4 milligrams of THC per container. Their central argument is “the myriad of concerns that have been raised by state attorneys general, law enforcement organizations and public health advocates.” It’s nothing we haven’t seen before from alcohol manufacturers. But this time, by citing state attorneys general, they are presenting evidence that they helped create. According to Politico’s recent reporting, lobbyists for Anheuser-Busch, Molson Coors and Diageo urged state attorneys general to support letters opposing any congressional delay of the hemp ban. In one email, a lobbyist for Anheuser-Busch reportedly asked North Dakota’s attorney general for help against “fringe U.S. Senators who would like to extend the [hemp] loophole by another year.” Shortly thereafter, the North Dakota attorney general joined 34 others who asked Congress to reject any effort to delay the ban. Now those companies’ trade groups cite the concerns of the attorneys general as if they arose on their own. Once this feedback loop is visible, the rest of the letter falls apart. It calls hemp’s regulatory proposals “last-minute” and “slapdash.” And yet the only thing slapdash here is the manufacturers’ muddled opposition to commonsense regulation. A year ago, five of these groups asked Congress to pull hemp THC products until a federal framework existed and said they “stand ready to work with Congress and the Administration” to write one. Now they have moved the goalposts, objecting that the frameworks before Congress have had no hearing or markup. Yet the ban they are defending hardly followed regular order. The full Senate voted to strip the hemp ban out of an appropriations bill in August 2025, but the ban came back three months later, shoved into the deal that ended the longest government shutdown in American history. In their new letter, the manufacturers call hemp “largely unregulated, untested and untaxed.” That’s not true, either. Minnesota taxes hemp edibles and beverages at 15 percent of gross receipts, plus sales tax. Kentucky’s alcohol regulators oversee hemp beverages, cap them at 5 milligrams of THC per serving and tax them at $1.92 a gallon, 24 times the state’s per-gallon excise tax on beer. The trade groups boast that alcohol is governed by more than 4,000 federal laws and regulations, and that they know “the significant time, effort and expertise required” to build such a system. Hemp businesses are asking to join that system. Two bipartisan bills would regulate hemp beverages like alcohol: the Lawful Hemp Protection Act, from Reps. Andy Barr (R-KY) and Angie Craig (D-MN), and the Beverage Regulatory Parity Act, from Reps. Beth Van Duyne (R-TX) and Greg Landsman (D-OH). The other two tiers of the alcohol business support those bills. Wine & Spirits Wholesalers of America, whose members distribute over 80 percent of the wine and spirits sold at wholesale, has endorsed both. Retailers including Total Wine & More formed the Beverage Alcohol Merchants Coalition to press for regulation. Alcohol manufacturers are the only tier of their own industry asking Congress to kill a category that Forbes has called a $38.5 billion industry. In this new letter, the trade groups also mention “non-intoxicating cannabidiol (CBD)” as if they support it, while demanding a law that would outlaw full-spectrum CBD products, which carry trace amounts of THC. In April, President Donald Trump asked Congress to keep full-spectrum CBD legal, and Medicare now covers it in a pilot program for products with up to 3 milligrams of THC per serving. Giving lip service to CBD while working to outlaw the CBD products the president asked Congress to protect is a dangerous game. Lobbyists for these alcohol manufacturers prodded attorneys general to warn Congress about a competitor so the hit job wouldn’t have their fingerprints on it, but Politico’s reporting has pulled back the curtain. Congress should see this for what it is: protectionism at its most cynical. Jim Higdon is a co-founder and the chief communications officer of Cornbread Hemp, based in Louisville, Ky. Read the alcohol industry’s hemp letter below: The post Alcohol Manufacturers Pushing Congress To Ban Hemp Products Live In Their Own Anti-THC Echo Chamber (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
The U.S. Postal Service (USPS) is pushing back against a new program from Georgia companies that plan to use certified mail to deliver marijuana to patients in the state’s medical cannabis program—but it says it is actively considering a policy change in light of the Trump administration’s move to federally reschedule the drug. “Medical marijuana in all forms is currently nonmailable under any circumstances,” Felicia Lott, senior public relations representative for USPS, told Marijuana Moment, “but the Postal Service and the United States Postal Inspection Service are currently reviewing the mailability of medical marijuana in light of the recent reclassification” by the Drug Enforcement Administration (DEA). “The DEA’s reclassification of medical marijuana was limited to marijuana products approved by the U.S. Food and Drug Administration and products subject to a state medical license as a Schedule III substance,” she said. “In the event medical marijuana is deemed to be mailable in the future, it will be treated the same as other prescription drugs containing controlled substances for mailing purposes.” It’s not clear why USPS is conducting a review about a potential policy change instead of automatically allowing state-licensed medical cannabis to be shipped in the mail given that it became a federally legal Schedule III substance under an order issued by Attorney General Todd Blanche in April. Lott did not immediately respond to Marijuana Moment’s follow-up questions about how soon USPS may arrive at a decision on mailability of Schedule III state-licensed medical cannabis, or where and how the ultimate decision would be announced to the public and stakeholders. On Tuesday, Botanical Sciences, a Georgia-licensed medical marijuana provider, and Edibles.com, a sister company of Edible Arrangements, announced that they are partnering on what they said is the “nation’s first medical cannabis shipping program”—with a spokesperson telling Marijuana Moment that they planned to use USPS certified mail for the shipments. The effort comes weeks after the Georgia Access to Medical Cannabis Commission (GMCC) approved regulations that allow medical cannabis deliveries in the state, with officials specifically saying that USPS and private carriers like FedEx, UPS and DHL could participate. Andrew Turnage, executive director of GMCC told Marijuana Moment on Wednesday that he is “pleased to see” USPS “finally doing what states did seven months ago, which is to read the DEA rescheduling order.” “States are decades ahead of federal agencies with marijuana regulation and stand ready as a qualified and experienced resource to help the feds get it right,” he said. “Hopefully USPS will ‘get it right’ without the Government Accountability Office having to weigh in on what’s right there in black and white.” Meanwhile, a pair of Republican U.S. Senators sent a letter last month urging USPS not to participate in medical marijuana deliveries in Georgia or other states. “It is our understanding that marijuana cannot currently be mailed at all using the USPS,” Sens. James Lankford (R-OK) and Ted Budd (R-NC) said in a letter to Postmaster General David Steiner. “However, some states are under a different impression.” “While Georgia does not have the authority to alter current USPS regulations, we are concerned that USPS will alter its regulations to allow for these shipments,” the GOP senators wrote in the letter. “We strongly oppose any effort to allow the shipment of marijuana.” Another USPS official, when contacted by Marijuana Moment in August, declined to clearly state the agency’s position on participating in medical marijuana deliveries. Nikolaj Hagen, a senior public relations representative for USPS, pointed to general regulations on the mailability of controlled substances. USPS’s Lott, in her email to Marijuana Moment this week, also cited the same rule, saying it “provides the regulatory framework for the mailability of hazardous or restricted materials, including prescription drugs containing controlled substances.” The regulations state that if distribution of a controlled substance is unlawful, “then the mailing of the substance is also unlawful.” Mailing of controlled substances in domestic mail, they say, is only acceptable under three conditions—perhaps the most applicable of which allows shipping of prescription medications “when mailed by drug manufacturers or their registered agents, pharmacies, medical practitioners, or other authorized dispensers, as permitted by 21 CFR § 1307.11, or in compliance with any regulation of the FDA or other applicable law.” While state medical marijuana laws have allowed patients to access it via doctors’ recommendations, and not the formal prescription process due to federal prohibition, the cannabis rescheduling order that Attorney General Todd Blanche issued in April contains a provision that seems to deem those recommendations as prescriptions for the purposes of federal law. Meanwhile, as USPS weighs a potential policy change on the mailability of medical marijuana, other federal agencies are also taking steps in response to the Trump administration’s rescheduling move. In April, the U.S. Department of the Treasury and Internal Revenue Service (IRS) said they plan to issue new tax guidance for the marijuana industry following the rescheduling announcement. Rescheduling will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions they’re currently barred from under an IRS code known as 280E that doesn’t apply to Schedule III substances. The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) also recently posted a draft update to gun purchase form to acknowledge the federally legal status of medical marijuana under rescheduling. The Drug Enforcement Administration (DEA) has launched a process to federally register state-licensed medical cannabis businesses. The Department of Transportation, on the other hand, issued guidance saying that use of state-legal medical cannabis is still no excuse for a positive drug test by truck drivers, pilots and other safety-sensitive workers. The Department of War issued a memo making clear that marijuana use by military service members and civilian employees of the department remains prohibited, even under federal cannabis rescheduling. The post USPS Says Medical Marijuana Isn’t Mailable ‘Under Any Circumstances,’ But Weighs Possible Policy Change Under Rescheduling appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
Marijuana Moment: New medical cannabis delivery plan involves USPS (Newsletter: November 18, 2026)
Tokeativity posted a topic in Marijuana Moment
NC gov’s marijuana council; Federal hemp debate heats up with new bill; Congressional psychedelics hearing; TX legalization revenue Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on. Check us out on Patreon and sign up to give $25/month today: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN) filed a bill to prevent the federal recriminalization of hemp THC products that’s scheduled for next month and replace it with a system of regulations as an alternative to prohibition. Rep. James Comer (R-KY) said the best shot for keeping hemp THC products federally legal is by attaching provisions to a must-pass spending bill—saying that their currently planned recriminalization on December 11 “makes me so mad because the industry is working, and it’s a huge success story.” Georgia companies are launching a new medical cannabis delivery service under newly enacted state rules using U.S. Postal Service certified mail—even as the federal agency refuses to clarify its stance on marijuana’s mailability in light of rescheduling and as U.S. senators press it not to participate. The House Veterans’ Affairs Subcommittee on Health will hold a hearing on Wednesday focused on increasing military veterans’ access to psychedelic treatments—with officials from the U.S. Department of Veterans Affairs set to testify alongside medical professionals and researchers. The North Carolina Advisory Council on Cannabis that was appointed by Gov. Josh Stein (D) met to discuss draft recommendations for a final report that is due next month—including state control of marijuana dispensaries and other issues such as taxes, expungements, potency and packaging rules. A Texas senator said he wants to use revenue from marijuana legalization to fund Gov.-elect Gina Hinojosa’s (D) plan to send $1,500 economic relief checks to every household in the state. Veterans of Foreign Wars and other military veterans groups sent a letter urging congressional leaders to keep hemp THC products federally legal by calling off a ban scheduled for next month and replacing it with regulations for the industry. Dasheeda Dawson, a former New York City and Portland cannabis regulator, argues in a new Marijuana Moment op-ed that the blue wave in this month’s elections “can open doors” to reform but that sustainable and equitable change “requires the courage to build something better on the other side.” “Some of the states that have struggled most to translate cannabis equity into meaningful outcomes have been led by Democrats. Some of my most difficult conversations about what equity actually means happened in jurisdictions where political leaders embraced it the loudest… Somewhere between designing markets, allocating licenses and determining who gets to participate, the fight for freedom became consumed by the business of legalization. Meanwhile, criminalization persists, stereotypes remain embedded in public policy and access to the plant is still treated as a privilege to be negotiated.” / FEDERAL The Department of Justice’s Office of the Pardon Attorney submitted a routine request for permission from the White House Office of Management and Budget to continue collecting public information via the application for certificates of pardons for federal marijuana offenses that was initiated by President Joe Biden, estimating that a “potential pool of approximately 350 applicants may apply.” Sen. Chuck Grassley (R-IA) and six other senators sent a letter urging the Drug Enforcement Administration and Food and Drug Administration to explain and reconsider changes to an emergency scheduling order for kratom-related substances. / STATES California’s attorney general touted enforcement efforts against illegal cannabis operations. Attorneys for Virginia’s Senate president pro tempore, who is facing federal marijuana and corruption charges, are asking a judge to sanction Attorney General Todd Blanche and Federal Bureau of Investigation Director Kash Patel over comments they made at a press conference about her indictment. New Hampshire senators discussed the prospects for legalizing marijuana in the 2027 session. Massachusetts regulators approved rules allowing drive-thru windows at marijuana retailers. Vermont regulators began accepting applications for cannabis event permits. Michigan regulators filed complaints against marijuana businesses over alleged violations. Mississippi regulators published a frequently asked questions document about medical cannabis. Oregon regulators will consider changes to rules on the hemp registry application process on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL Nigerian African Action Congress presidential candidate Omoyele Sowore is calling for cannabis legalization. / SCIENCE & HEALTH A study found that “cannabidiol-rich hemp cultivars suppress cannabis aphid populations and alter detoxification gene expression.” A study of rats concluded that “chronic intermittent administration of a ∆9-THCA-enriched extract reconfigures the aged phenotype, prioritizing metabolic maintenance and neuroprotection,” suggesting that full-spectrum cannabinoids serve as a viable geroprotective for neuroinflammatory stress.” / ADVOCACY, OPINION & ANALYSIS A poll of current and retired Massachusetts law enforcement officers found that 92 percent want to keep licensed marijuana sales legal. The Canadian Association of Social Workers is asking lawmakers to decriminalize drugs. / BUSINESS Glass House Brands Inc. reported quarterly revenue of $56.8 million and a net loss of $10.1 million. POSaBIT Systems Corporation reported quarterly revenue of $2.3 million and a loss of $0.1 million. / CULTURE Podcaster Joe Rogan again suggested that opposition to cannabis reform was partly to blame for Republicans’ losses in the midterm elections. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post New medical cannabis delivery plan involves USPS (Newsletter: November 18, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net -
I've lately began the weblog, the data a person supply on this website offers assisted me personally significantly. Many thanks with regard to all your period & function. mpo888 link
-
Blumenauer Lauds House Passage of Federal Legislation to Give Cannabis Businesses Access to Banking Services
yuvi001 commented on Lisa's blog entry in Tokeativity HQ Blog
Enjoying your downtime reaches a whole new level when you utilize a trusted Independent bijwasan Escorts Service for your social and personal needs. The remarkable attention to detail and friendly nature of the companions guarantee a wonderfully stress-free, delightful, and memorable evening from start to finish. -
hannana started following Eyes Wide Love: Tokeativity Back to the 90’s
-
Eyes Wide Love: Tokeativity Back to the 90’s
hannana commented on Lisa's blog entry in Tokeativity HQ Blog
Word association games connect words through shared meanings, daily games experiences, or familiar concepts. -
Yatesda started following Apply to Tokeativity® Canna Mama Con
-
This sounds like such a fantastic initiative! Connecting canna mamas and sharing wisdom is so important. I love the idea of creating a supportive online space. It makes me think about how we often crave community, even when dealing with big, impactful topics. This conference could really be a Solar Smash for those looking for genuine connection and knowledge!
-
Sienna Crook started following What Do Abortion and Cannabis Have in Common?
-
What Do Abortion and Cannabis Have in Common?
Sienna Crook commented on Lisa's blog entry in Tokeativity HQ Blog
Navigating this tightrope requires empathy and open minds. I remember a workplace ethics committee grappling with a similar conundrum, where individual beliefs clashed with company policy, almost like a real-life Connections Game. - Last week
-
A bipartisan duo of U.S. senators have filed a new bill that would prevent the federal recriminalization of hemp THC products that is currently scheduled to go into effect next month while instituting a set of new regulations as an alternative to prohibition. Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN) introduced the Hemp Guardrails Act on Tuesday. The legislation would raise the legal threshold for hemp to one percent total THC on a dry-weight basis—with an exception to go above that for in-process materials—and create a new category of prohibited cannabinoids that include delta-8 THC, delta-10 THC and THC-O-acetate , while also restricting the manufacturing or synthesizing of those compounds outside of the hemp plant. The legislation would continue allowing conversions for CBD, delta-9 THC and other natural hemp compounds outside of the plant, but only if it results in a naturally occurring end product. Raw floral hemp material, smokable hemp flower or hemp pre-rolls would be barred from entering interstate commerce. There would be an age limit of 21 to possess and consume hemp cannabinoid products, and they would need to be grown, processed and packaged within the U.S. to be legal. The bill also seeks to establish categories for hemp-derived products and supplements under the Federal Food, Drug, and Cosmetic Act and directs the Food and Drug Administration (FDA) to set rules for packaging, labeling, manufacturing, testing, registration and recalls within 180 days. Certain industrial hemp products not containing cannabinoids—such as seed, seed oil, and hempseed protein—would be considered food additives, subject to applicable safety requirements. The legislation preserves the authority of states to enact stricter hemp regulations but prohibits them from blocking the interstate transportation of compliant products. “We’re taking a commonsense approach to this issue,” Sheehy said in a press release. “Our bill will put every bad actor in the hemp space out of business and keep intoxicating products out of the hands of children. It will also stop Congress from turning the farmers, veterans, and cancer patients who rely on these products into criminals overnight.” Klobuchar, who was recently elected governor of Minnesota and will be leaving the Senate soon, said her state is “is a national leader in hemp” and “has shown that we can protect kids and support responsible hemp businesses.” “But a looming federal ban on hemp products is threatening farmers, brewers, small businesses, and consumers across Minnesota and the country,” she said. “This new bill with Senator Sheehy would keep safe hemp products on store shelves, protect consumers from dangerous products, and ensure that farmers and small businesses can continue to operate, grow, and create jobs.” Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that redefined hemp to make it so only products with 0.4 milligrams of total THC per container would remain legal after November 12. Under provisions included in a separate funding bill Trump signed this September, however, the effective date of the ban for most products was pushed back to December 11 to give lawmakers more time to craft regulations for hemp derivatives. There was a carve-out, however, to allow the recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” Jonathan Miller, general counsel for the U.S. Hemp Roundtable, said that “all responsible players in the hemp industry are united in support of the bipartisan Hemp Guardrails Act of 2026.” “The bill would not only preserve the vibrant hemp industry threatened by an ill-advised ban, it would also serve to protect children and vulnerable consumers by cracking down on bad actors,” he said. “The bill says: No to sales to minors. No to imports from China. Yes to good manufacturing practices and third-party testing. No to copycat products that appeal to kids. No to ‘gas station weed.’ Yes to non-intoxicating CBD and low-dose hemp beverages.” Meanwhile, a top GOP congressman is pushing to attach provisions to keep hemp products legal to larger spending legislation in the coming weeks. “The best opportunity, in my opinion, is to get this on a bill that is going to pass,” Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, said. “The only bill that I think that absolutely, positively has to pass is going to be another continuing resolution, which is what got us here to begin with.” Rep. Morgan Griffith (R-VA) similarly recently floated the idea of including hemp extension and regulation language in a broader budget reconciliation bill. Miller of U.S. Hemp Roundtable said he group is looking forward to working with Sheehy and Klobuchar to secure their bill’s provisions “inclusion in the next spending bill or continuing resolution that will keep the government open for business.” The Congressional Research Service noted in a recent report that the Food and Drug Administration (FDA) is now more than nine months late in fulfilling a legal mandate to publish a list of known cannabinoids and guidance on hemp product containers that was included in last year’s hemp product recriminalization legislation. Aside from the new Senate legislation, a number of lawmakers from both chambers and both parties have filed or are circulating a growing number of bills to prevent the scheduled federal recriminalization of hemp THC drinks and other products. Comer, for example, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. Reps. Beth Van Duyne (R-TX) and Greg Landsman (D-OH) introduced a bill to keep hemp THC drinks legal while taxing and regulating them like alcohol. Separately, Rep. Andy Barr (R-KY), filed a lengthier proposal to prevent the federal recriminalization of hemp THC products and put in place a number of regulations for manufacturing, labeling, sales and taxation of hemp-derived products, including an age limit of 21. Griffith and Rep. Marc Veasey (D-TX) introduced a measure to allow continued sales of hemp THC products to adults over 21, with new regulations, Several Republican lawmakers recently spoke to Marijuana Moment about the kinds of rules they would like to see enacted to keep hemp THC products legal. This week, Veterans of Foreign Wars and other military veterans groups sent a letter urging Congress to keep hemp THC products legal. The post Bipartisan Senators File Bill To Keep Hemp THC Products Federally Legal As Next Month’s Scheduled Ban Looms appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
A North Carolina governor-appointed cannabis commission is reviewing draft recommendations as it prepares to issue its final report next month on how the state should legally regulate THC—including state control of marijuana dispensaries. Members of the North Carolina Advisory Council on Cannabis have been meeting regularly since Gov. Josh Stein (D) formed the body last year, including in subcommittees focused on market structure, taxation and public safety—and the full panel came together on Tuesday to discuss a set of recommendations that will inform a final report that is due by the end of the year. Among other issues, the panel appears to be settling on recommending that lawmakers create a regulated adult-use marijuana program allowing possession by and sales to adults over 21 years of age that would include specific protections for patients without creating a separate and distinct medical cannabis program. One of the more notable draft recommendations surrounds the structure of the legal market. While private businesses would be licensed to cultivate and process marijuana products, the state would play a more active role in controlling cannabis retail outlets similar to how it handles liquor, beer and wine through the Alcoholic Beverage Control Commission (ABC). Lawrence H. Greenblatt, the state health director and chief medical officer at the North Carolina Department of Health and Human Services, said at the meeting that the state would “rather tightly” oversee sales to consumers, which would “allow for retail outlets that essentially are not promoting more use of cannabis products.” “It’d be essentially kind of clean, no posters, no advertising,” he said, noting it would be similar to the cannabis sales model in Quebec, Canada. “The state would contract that out to a vendor or vendors, and wouldn’t actually own the product,” Greenblatt said, suggesting that the model wouldn’t run afoul of federal laws. Rather than create separate systems for recreational marijuana, medical cannabis and hemp products, the council is focused on regulating the intoxicating molecule of THC through the creation of a new regulatory body to oversee the overall industry. The draft recommendations discussed at Tuesday’s meeting include provisions concerning advertising restrictions, rules for packaging and labeling, standards for product potency and testing, expungements for prior convictions, banning public smoking and vaping, youth prevention efforts, law enforcement resources and impaired driving prevention. When it comes to taxation, the panel appears to be preparing to recommend that lawmakers choose between taxing marijuana by price, as most other states have done, or applying a tax by based on products’ THC potency. Greenblatt said that the council has undertaken a “tremendous lift” in recent months. “This is really hard, complicated material. We’ve asked a lot of you, a lot of reading, meetings, listening to speakers, thinking—some great conversation and insights,” he said. “And this is a really important issue for the state—important for public health and public safety.” “As we all know, North Carolina is facing a public safety and public health problem,” Greenblatt said. “Cannabis with intoxicating levels of THC is widely available and unregulated. Concurrent lack of regulation, including no minimum age for sale, no labeling requirements or testing standards, poses a threat to all North Carolinians, particularly our youth.” Members of the council did not vote on the recommendations at Tuesday’s meeting but will do so in the coming weeks ahead of the final report being issued. The council’s consideration of the draft recommendations comes shortly after Democrats took control of the state House of Representatives in this month’s midterm elections and narrowed Republicans’ majority in the Senate to just one seat—which advocates believe better positions the state to move ahead with marijuana reform than ever before. House Speaker-elect Robert Reives (D) said following the election that “decriminalization of marijuana has been on top of everybody’s minds.” The incoming top House official also spoke about the benefits of medical cannabis, particularly for military veterans. “I’ve got a veteran family,” he said. “My dad served. My uncle served, and all that. And it’s just, I want everything we can to help our veterans, and that is one of the top items that people have talked about.” The North Carolina Senate under GOP control has already approved legislation to legalize medical cannabis several times during recent sessions, though House Republican leadership has refused to allow the reform to advance. Stein, meanwhile, supports broader marijuana legalization and convened the state council last year to evaluate options for updating cannabis laws. The governor-appointed cannabis commission in North Carolina issued an interim report in April initially recommending that the state move away from a criminalization-based approach to the plant and toward a system of “robust” regulations that provide for adults’ legal access to THC products. The North Carolina Advisory Council on Cannabis said in the initial report that that the current “absence of regulation for North Carolina’s intoxicating cannabis market raises numerous concerns,” noting that hemp products are readily available yet largely unregulated and that marijuana remains prohibited altogether in the state, even for medical use. “Compared to regulated marijuana frameworks in other states, this environment presents identifiable risks,” the interim report says. “While some operators voluntarily implement consumer protection protocols, these safeguards are not required under state law.” Stein, for his part, thanked the group for its “expertise, hard work, and thoughtful deliberation” put into the initial report and reiterated his support for legalizing marijuana. Members are tasked with developing and submitting initial recommendations on a “comprehensive cannabis policy, including any proposed legislation,” with a final report due by December 31. Meanwhile, the governor has continually pressured the GOP-controlled legislature to advance marijuana reform. In August, Stein called on lawmakers to broadly legalize and regulate cannabis in a way that “protects kids” while they were considering a narrower bill to restrict hemp THC and kratom products. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In September, a poll showed that North Carolinians strongly support legalizing medical marijuana, and that a majority wants to go even further by legalizing cannabis for recreational use. During his time as the state’s attorney general, Stein led a separate task force under then-Gov. Roy Cooper (D) that examined racial injustice issues and ultimately recommended decriminalizing marijuana and studying broader legalization in response to racially disparate enforcement trends. A tribe in North Carolina, the Eastern Band of Cherokee Indians, launched the state’s first marijuana dispensary in 2024—despite the protests of certain Republican congressional lawmakers. Democratic lawmakers recently filed legislation to allow voters to decide whether to legalize marijuana for personal or medical use at the ballot box this November, though that did not advance. Meanwhile, bipartisan North Carolina lawmakers have been stepping up the push for psychedelics reform legislation. The post North Carolina Governor’s Cannabis Council Weighs Recommendations For Legally Regulating THC, Including State-Controlled Dispensaries appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
Marijuana Moment: The Election’s Blue Wave Won’t Save Cannabis Equity, But A New Blueprint Might (Op-Ed)
Tokeativity posted a topic in Marijuana Moment
“Some of the states that have struggled most to translate cannabis equity into meaningful outcomes have been led by Democrats.” By Dasheeda Dawson, The WeedHead™ The Democrats won big. Cannabis legalization could be next. But will cannabis equity and freedom actually win? That’s the question we should be asking after the 2026 midterms, as shifting political dynamics renew optimism about cannabis reform in states like Texas, Pennsylvania, North Carolina and Georgia. Texas lawmakers have introduced legalization legislation. North Carolina’s legislative leadership has floated decriminalization. Across the country, new political possibilities are reopening conversations about cannabis policy. For advocates who have spent decades fighting prohibition, these developments offer renewed opportunity. Before we celebrate the next wave of legalization, we should reckon with what the last one taught us. Some of the states that have struggled most to translate cannabis equity into meaningful outcomes have been led by Democrats. Some of my most difficult conversations about what equity actually means happened in jurisdictions where political leaders embraced it the loudest. Cannabis transcends party lines. Education and access is a human rights issue, and getting it right is everyone’s responsibility. I’ve spent a decade in this work, five of those years inside government. I managed Portland, Oregon’s cannabis program and served as the founding executive director of Cannabis NYC. Along the way, I’ve been an advocate, educator, entrepreneur and patient. From every one of those seats, I’ve witnessed the distance between legislative promises and lived experience. The next chapter of cannabis reform needs a new blueprint. The Equity Paradox Equity programs were built to repair the harms of prohibition. For too many licensees, they’ve become the newest harm. In conversations with equity licensees across the country, more than half have told me some version of the same thing: if they knew then what they know now, they wouldn’t have pursued a license. These are field observations, gathered one licensee at a time, and the sentiment is consistent enough to demand attention. New York offers a troubling example. Its Conditional Adult-Use Retail Dispensary (CAURD) program created a historic opportunity for justice-involved entrepreneurs. Some have built successful businesses, created jobs and opened doors that prohibition kept closed for generations. Many others have spent years navigating delays, debt, real estate challenges and costly compliance requirements. The Dormitory Authority of the State of New York (DASNY) -backed Social Equity Cannabis Investment Fund became a case study in how assistance meant to accelerate opportunity can become another way to incarcerate people through financial burdens. Imagine surviving criminalization, qualifying for an equity license and then discovering that participating legally could threaten your health and financial future. We built pathways to ownership without building the conditions for ownership to succeed. That’s the equity paradox. The next state to legalize should confront it before repeating it. Good Legislation Is Only The Beginning Equity looks great on paper. Implementation is where it lives or dies. I learned that firsthand in Portland. The city’s cannabis equity and community reinvestment commitments existed before I arrived. Building the systems to deliver on those commitments required intentional leadership, community engagement and operational discipline. Across the country, cannabis tax revenue has been celebrated as a tool for repairing communities disproportionately harmed by prohibition. The gap between allocating those dollars and delivering measurable benefits can be enormous. A budget allocation is a promise. A measurable improvement in people’s lives is an outcome. We’ve spent far too much time applauding promises. Licensing works the same way. The number of equity licenses issued tells us little about whether those businesses are profitable, whether their owners are building wealth or whether their communities are better off. A license count is a headline. A profitable equity business is proof. Economic participation, particularly dispensary ownership, has dominated the definition of cannabis equity. The CHEM Pillars of Health Equity measure it across four interconnected dimensions: social equity in the structures and relationships that sustain collective well-being; economic equity in fair access to resources and sustainable livelihoods; environmental equity in the places where communities live, work, and grow; and human equity in dignity, ancestral knowledge, and the right to make informed decisions about one’s own health. Dispensary ownership speaks to one pillar. Cannabis reform has to answer for all four. A community can generate millions in cannabis sales while its residents remain criminalized, patients struggle with affordability and promised reinvestment never arrives. A thriving cannabis market and a healthy community are two different achievements. That should change how we define success. We Legalized The Market And Kept The Stigma While working in government, I discovered that some of the people shaping cannabis policy understood the least about the plant. It was one of the most frustrating parts of the job. Even in New York City, where I spent considerable time educating colleagues across agencies, including public health and mental health officials, deeply rooted stereotypes continued to shape conversations about cannabis. Science has evolved. Public opinion has shifted. Laws were changing. Institutional understanding lagged behind all three. That knowledge gap has consequences. We still impose arbitrary possession limits, restrictive home cultivation rules and expensive compliance requirements while treating cannabis activity outside licensed commerce as inherently suspect. We cannot regulate our way out of ignorance. Texas offers a particularly revealing example. An expansive hemp-derived cannabinoid market emerged under the 2018 Farm Bill, including products marketed as “THCA flower.” THCA is naturally abundant in marijuana flower until heat converts it to THC so the distinction was an absurd loophole. That market rapidly grew with limited oversight, only to face sweeping restrictions and renewed criminal penalties. Now, with a federal hemp ban looming, Texas lawmakers are introducing proposals to legalize adult-use cannabis. Texas has turned the same plant into a commodity, then a crime and now a campaign promise. What have lawmakers learned from this experience? Judging by the latest proposals, not nearly enough. Newly introduced Texas legislation proposes a two-ounce possession limit and permits twelve plants for home cultivation. Sounds great, except the possession threshold preserves an arbitrary line between lawful conduct and criminal exposure. Twelve plants per person should be the minimum for meaningful home cultivation rights, with additional allowances reflecting patient needs, caregiving, genetic preservation and personal autonomy. Full decriminalization should be the foundation of reform. Public safety standards should address actual harms, and an arbitrary quantity threshold should never be the line between a law abiding citizen and a criminal. Protect the people. Expand their ability to understand and benefit from the plant. That’s the job. Federal Reform Is Exposing The Contradictions The federal government is finally running into the contradictions state regulators have lived with for years. The Schedule III framework recognizes cannabis’s accepted medical use while drawing a federal distinction between qualifying medical activities and state-licensed adult-use operations. Regulators know how artificial that separation is. The same cannabis product can be sold through either market, often to consumers seeking the same benefits. Sleep, pain and anxiety consistently rank among the leading reasons people shop in adult-use cannabis markets. Focus is another common motivation. Cannabis remains medicinal no matter which dispensary counter it crosses. Federal policy is still constructing separate categories of legitimacy around the same plant, risking an unprecedented regulatory divide within a single controlled substance. For years, “regulate cannabis like alcohol” was the rallying cry of legalization campaigns. It made a great slogan. Cannabis consumer behavior tells a more complicated story. An over-the-counter health and wellness model offers a more relevant starting point for many cannabis products, borrowing elements of alcohol regulation where warranted. A whole-plant approach could go further, establishing a unified regulatory foundation for cannabis that recognizes its medicinal, agricultural, industrial and adult-use applications. Product standards could reflect actual composition, effects and risks, while licensing and compliance requirements accommodate different activities within one coherent legal framework. That approach allows states to meet federal medical requirements where necessary while keeping one market for one plant. Our laws should follow the science of the plant. Its classification has followed politics long enough. Instead, policymakers remain consumed with developing markets, establishing regulatory categories, and choosing economic winners and losers. Meanwhile, sixteen governors have once again urged Congress to pass the SAFE Banking Act. We’ve been here before. As chair of the Cannabis Regulators of Color Coalition, I helped challenge the assumptions behind this legislation years ago. SAFE protects financial institutions that serve cannabis businesses. It guarantees nothing about equitable lending or meaningful access to capital for the entrepreneurs who need it most. The familiar story goes like this: cannabis businesses run on cash, and banking reform will solve the crime that cash attracts. Regulators on the ground have seen a far more complicated reality. Access to affordable capital is the bigger, harder problem which remains unresolved with the proposed legislation. And the same bill, carrying the same promises, still dominates federal reform conversations. We’ve spent years trying to free the money while leaving the plant and the people federally criminalized. At the same time, federal restrictions on hemp-derived cannabinoids threaten another segment of the cannabis economy, deepening the contradictions between federal policy and state legalization. The plant hasn’t changed. Our rules keep changing around it. Rescheduling may benefit qualifying medical operators. Full descheduling, decriminalization, whole-plant access and the federal treatment of adult-use businesses remain unresolved. Those questions deserve to lead the next chapter of reform. The Next Wave Needs A New Blueprint Every generation of legalization has fixed some of the last one’s mistakes and made new ones of its own. Early adult-use states largely left equity out of their statewide frameworks, while cities like Oakland, Los Angeles and Portland pioneered local efforts to address the harms of prohibition. Massachusetts became the first state to establish a statewide cannabis social equity effort, followed by Illinois, New York, New Jersey, Maryland and others that built equity into their legalization frameworks. Each generation has expanded the conversation, created opportunities, and exposed challenges for the next. That’s progress. Progress also demands accountability. We have to be willing to critically grade our own work. Through that lens, we must acknowledge where we’ve lost the plot. Somewhere between designing markets, allocating licenses and determining who gets to participate, the fight for freedom became consumed by the business of legalization. Meanwhile, criminalization persists, stereotypes remain embedded in public policy and access to the plant is still treated as a privilege to be negotiated. We’ve become experts at designing cannabis markets while still struggling to define cannabis freedom. The next wave also demands a shift in advocacy. For too long, the pursuit of whatever legislation can pass has shaped the boundaries of what we’re willing to fight for. Political feasibility has become a substitute for policy vision. Our responsibility as advocates is to establish the foundations of freedom and hold legislation accountable to them. Full decriminalization, meaningful cultivation rights, science-based education, health autonomy and equitable access must anchor the framework from day one. Texas, Pennsylvania, North Carolina, Georgia and other states entering a new political chapter have the benefit of our collective experience. They can build on what worked, confront what failed, and write policies that start with the rights we intend to protect. The markets can follow. The real measure of cannabis equity must be rooted in measurable outcomes: freedom from criminalization and collateral consequences, more people educated and empowered to cultivate and access the plant, financially sustainable small businesses and community reinvestment that actually reaches the people it was intended to serve. Protecting our environment and preserving the plant’s cultural, medicinal, and agricultural value must be part of that equation. That’s how we measure progress. That’s how we measure equity. Political shifts can open doors. Sustainable reform requires the courage to build something better on the other side. The blue wave may set the stage for another chapter of legalization. After decades of prohibition and years of imperfect implementation, we owe ourselves more than another collection of licenses, tax revenue projections and recycled federal proposals. The next blueprint must measure how many people we’ve freed, how much knowledge we’ve shared, and how well we’ve protected the plant for generations to come. Free the plant. Free the people. Dasheeda Dawson is a cannabis policy strategist, educator, entrepreneur and former government regulator in New York City and Portland, Oregon. She is the founder of The WeedHead™ & Company and the bestselling author of How to Succeed in the Cannabis Industry: The Blueprint They Never Gave Us, 4th Edition. The post The Election’s Blue Wave Won’t Save Cannabis Equity, But A New Blueprint Might (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net -
Marijuana Moment: Congress To Hold Hearing Focused On Psychedelic Therapy For Military Veterans This Week
Tokeativity posted a topic in Marijuana Moment
A congressional committee is scheduled to hold a hearing about increasing military veterans’ access to psychedelic treatments this week—with officials from the U.S. Department of Veterans Affairs (VA) set to testify alongside medical professionals and researchers. The hearing—titled “Psychedelic-Assisted Therapies for Veterans: The Path Forward”—will be held before the House Veterans’ Affairs Subcommittee on Health on Wednesday. Andrew Gradison, a senior advisor to the under secretary for health at the VA’s Veterans Health Administration (VHA), said in written testimony posted by the panel that President Donald Trump’s administration “has taken decisive action to accelerate psychedelic research and eliminate regulatory obstacles that have historically slowed progress.” He cited an executive order Trump signed in April with the aim of expediting psychedelic therapy access, saying it was the “first EO in American history dedicated specifically to accelerating clinical research and regulatory review of psychedelics, underscoring the president’s firm commitment to advancing emerging treatments for serious mental illnesses.” Since then, “VA’s psychedelics research portfolio has grown substantially in response, and our interagency partnerships are driving rapid and safe scientific advancement,” Gradison said, noting that it is now conducting 21 active clinical studies on psychedelics to treat mental health conditions. He specifically cited a clinical trial VA announced in August to investigate whether psilocybin can help military veterans who are struggling with treatment-resistant depression. TOMORROW @ 2:15 PM ET: Health Chairwoman @RepMMM will lead an oversight hearing examining psychedelic-assisted therapy options and the path forward for veterans. pic.twitter.com/qPKf16M6RF — House Committee on Veterans' Affairs (@HouseVetAffairs) November 17, 2026 “VA strives to lead the Nation in exploring the therapeutic potential of psychedelic drugs,” Gradison said, adding that the department recognizes that substances such as psilocybin, MDMA and ibogaine “offer promising potential for the complex mental health conditions affecting many of the Veterans we treat.” The VA official also touted a memorandum of understanding his department signed with the Department of Health and Human Services (HHS) in July outlining a partnership to collaborate on research and development of psychedelic medicines to treat people struggling with serious mental health conditions. The agreement, he said “lays the groundwork for unprecedented VA-HHS operational cooperation on psychedelic trials.” “As we prepare for potential clinical implementation, VA remains anchored in three core priorities: first, ensuring Veteran safety above all else; second, building a rigorous body of evidence to determine which treatments work for which Veterans; and third, laying the foundation so that, pending all regulatory approvals, VA is positioned to be the first health care system in the Nation to deliver these treatments to Veterans. These priorities shape every research, clinical, and policy decision we make in this space.” Gradison said VA has already identified 10 facilities “with the expertise, physical space, and operational capacity needed to serve as early implementers, educators, or sites-in-training” with teams that are “experienced in psychedelic research protocols and are preparing to translate that experience into clinical care that maximizes Veterans’ safety if treatments are approved.” The VA official emphasized, however, that the department discourages self-medicating with psychedelics or using them to replace other mental health treatment options. Also testifying at Wednesday’s hearing will be Leith States, a former HHS acting assistant secretary for health who now runs the consulting firm States Strategies. He is calling on Congress to support psychedelic research that “answers the clinical questions veterans and clinicians face,” while requiring VA to set and track milestones for clinical readiness and access and holding the department accountable for patient safety and lasting improvement in veterans’ lives. “Doing our duty means investigating promising treatments with urgency and discipline, speaking plainly about what we know, and preparing the people and systems needed to deliver responsible, safe, and ethical care,” States’s testimony said. “Veterans’ needs should determine our priorities as we build on useful work across administrations, examine shortcomings honestly, and sustain the progress clinicians and researchers need to improve care.” The testimony of Marion Coe of Pinney Associates references her work to compile responses to a request for information (RFI) the bipartisan Congressional Psychedelics Advancing Therapies (PATH) Caucus issued seeking input from experts about how to best set up a regulatory framework for psychedelic medicines. Among other points, she emphasized that VA must “begin preparing its clinical infrastructure and workforce” before Food and Drug Administration (FDA) approval of any psychedelic treatments “if it is to be ready to expand access as rapidly and as safely possible.” “The central challenge is not simply whether these medicines can work,” Coe said. “It is whether we can build the infrastructure necessary to deliver them safely, ethically, and to the veterans who need them, and help as many patients who could benefit as safety and other considerations allow.” Mark Niciu, an assistant professor at the University of Iowa, used his testimony to explain his research addressing what he called the “major hurdle” of functional unblinding in psychedelic research, which is when participants and evaluators are able to tell which subjects are in the control or experimental group during a trial. “Expectancy bias is particularly salient in psychedelic medicine trials, where the drug’s effects are acute, intense, highly salient, and reinforced, for example, by the recent re-galvanization of classical psychedelics by the media, government, etc.,” he said. “When such drugs are compared with an inert or insufficiently matched placebo, participants and researchers immediately and accurately know their randomization assignment. In other words, there is ‘double’ functional unblinding, potentially affecting the thoughts and/or behaviors of both parties for the remainder of the trial.” Raquel Halfond, the senior director of evidence-based practice and health equity at the American Psychological Association, emphasized in her testimony the need for focus on transparency and accountability, infrastructure and associated therapy and workforce demands. “Each of these areas is necessary to make veteran protection and safety the utmost priority,” she said. The organization “encourages VA and all federal partners to adopt a stepped, interdisciplinary care model regarding the development of psychedelic-assisted therapy following rigorous and ethical research, with national minimum competencies; independent medical and psychological assessments; strong ethical safeguards and informed consent; on-site human monitoring; structured follow-up; and drug-specific staffing requirements,” Halfond said. “With strong VA research standards and clinical trial protocols being put in place, we are encouraged by the ability of the VA to lead the way with scientific rigor and integrity.” While not testifying in person at the hearing, Disabled American Veterans, Veterans of Foreign Wars, Special Forces Foundation and Mindbloom all submitted written statements for the record. Photo courtesy of Mark Groeneveld. The post Congress To Hold Hearing Focused On Psychedelic Therapy For Military Veterans This Week appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net -
Texas should legalize marijuana and use the revenue to fund the incoming governor’s plan to send a $1,500 economic relief payment to every household in the state, a Democratic senator says. “We can create new taxation as well that doesn’t affect families at home,” Sen. Roland Gutierrez (D) said in an interview with WFAA-TV. “Let’s look at cannabis.” The senator, who prefiled a bill last week to enact Gov.-elect Gina Hinojosa’s (D) proposal to send $1,500 checks to households across the state, criticized the state’s current laws—passed under a Republican legislature—that have allowed sales of hemp products in a way he said doesn’t provide for sufficient taxation. “Republicans legalized cannabis without ever taxing it in a real way,” Gutierrez said. “We can generate over $3 billion in taxing cannabis, clawing back the danger and the damage that they created over the last six years, and their amping up this hemp stuff across every convenience store in your community.” During the last legislative session, the legislature passed a bill to recriminalize hemp THC products that was ultimately vetoed by Gov. Greg Abbott (R). Following that veto, however, state agencies advanced restrictive rules that effectively banned many hemp products and which are currently being challenged in court. Meanwhile, Gutierrez’s bill for the $1,500 payments says that “extraordinary and sustained increases in the cost of housing, electricity, food, transportation, insurance, and other necessities have created a statewide household affordability emergency that threatens the ability of Texas households to obtain necessities and maintain stable housing.” The one-time checks to every household would be aimed at addressing what it calls the “immediate consequences of that calamity and protect the health, safety, and economic stability of residents of this state.” Texas Democrats won every statewide office on the ballot in this month’s midterm elections, as well as majority in the House of Representatives, but Republicans will maintain control of the Senate. Lt. Gov.-elect Vikki Goodwin (D), who will oversee the Senate in the role, said recently that legally regulating THC products will be one of her top priorities in the 2027 session. Democratic and Republican elected officials in Texas are discussing the possibility of teaming up across partisan lines to advance cannabis reform in the 2027 legislative session following this month’s election results that upended the GOP’s long-held dominance of the state. Podcaster Joe Rogan, who is based in Austin, said that Texas Republicans “passed some crazy laws banning THC products, and it’s probably cost them the election.” Goodwin said separately at a press conference this month that she is “look[ing] forward to working with all of the senators to work out those details” on cannabis legislation, saying she is “not interested in a full ban on THC.” Meanwhile, Rep. Wes Virdell (R) said that cannabis is an issue “where me and the Democrats can definitely align on.” “I think you’ll see very bipartisan bills come out of the House, and hopefully the Senate on those issues,” he said. Lawmakers in the House and Senate have already prefiled bills for the 2027 session to legalize recreational marijuana in Texas, expand medical cannabis access and enact other reforms. Hinojosa has said she wants to let Texas voters decide on marijuana legalization via a referendum, though under state law that would have to be a constitutional amendment placed on the ballot by the legislature. A strong bipartisan majority of Texans support legalizing or decriminalizing marijuana, according to recent polling. Voters in Houston this month approved a ballot initiative to make misdemeanor marijuana possession the “lowest possible enforcement priority” for local police while also banning no-knock warrants. Meanwhile, Sen.-elect James Talarico (D-TX) has said he wants to parter with President Donald Trump to federally legalize marijuana. The post Texas Should Legalize Marijuana And Use Revenue To Fund $1,500 Economic Relief Checks For Every Household In The State, Lawmaker Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
Two Georgia-based companies are teaming up on a new effort to deliver medical marijuana directly to patients under newly enacted state rules—and they plan to use U.S. Postal Service (USPS) certified mail for the shipments despite concerns that lawmakers have raised about the federal agency handling cannabis. On Tuesday, Botanical Sciences, a Georgia-licensed medical marijuana provider, and Edibles.com, a sister company of Edible Arrangements, announced that they will be partnering on what they said is the “nation’s first medical cannabis shipping program.” The effort comes weeks after the Georgia Access to Medical Cannabis Commission (GMCC) approved regulations that allow medical cannabis deliveries in the state, with officials specifically saying that USPS and private carriers like FedEx, UPS and DHL could participate. A spokesperson for the new partnership told Marijuana Moment on Monday that the companies will be using USPS certified mail to carry out the deliveries. “This system ensures patients can compliantly have these products shipped directly to their doors,” she said. “The platform requires us to ship the products to the address associated with their medical card and requires them to present a valid 21+ ID upon receipt. This is common for other Schedule III medications that patients commonly receive.” A spokesperson for federal agency, however, when previously contacted by Marijuana Moment, refused to clearly state whether it views delivering medical marijuana as federally legal, even under the Trump administration’s cannabis rescheduling move. They pointed to existing regulations on mailability of controlled substances without directly addressing the cannabis issue. Meanwhile, a pair of Republican U.S. Senators sent a letter last month urging USPS not to participate in medical marijuana deliveries in Georgia or other states. “It is our understanding that marijuana cannot currently be mailed at all using the USPS,” Sens. James Lankford (R-OK) and Ted Budd (R-NC) said in a letter to Postmaster General David Steiner. “However, some states are under a different impression.” “While Georgia does not have the authority to alter current USPS regulations, we are concerned that USPS will alter its regulations to allow for these shipments,” the GOP senators wrote in the letter. “We strongly oppose any effort to allow the shipment of marijuana.” The spokesperson for the new Georgia-based effort told Marijuana Moment that “it is commonplace for Schedule III drugs like ours to be shipped legally to patients.” “We followed the requirements outlined by the Georgia Medical Cannabis Commission (GMCC) and submitted our planned approach for their review and approval, which we received last week,” they said. “The goal is to ensure that products are purchased, shipped, and compliant under the Georgia medical programs. We’ve taken every step to ensure compliance at every stage of the patient’s journey.” Meanwhile, the companies say the delivery service will benefit patients, especially those who live in rural areas and don’t have convenient access to dispensaries or pharmacies that sell medical marijuana. “Georgia has created a new pathway to reach patients, and our partnership with Edibles.com allows us to translate that progress into equitable access,” Gary Long, CEO of Botanical Sciences, said in a press release. “Everything we do comes back to our commitment to serving Georgia patients and making medical cannabis more accessible to those who need it.” Thomas Winstanley, president of Edibles.com, said that “access and accountability should never be competing priorities.” “For too long, where a patient lives or their ability to travel has influenced their access to medical cannabis,” he said. “This partnership demonstrates how thoughtful regulation and technology can work together to remove those barriers without compromising the safeguards patients deserve for better quality of life.” Andrew Turnage, executive director of GMCC, the state medical cannabis regulatory agency, told Marijuana Moment on Tuesday that “it’s exciting to see licensees take advantage of the opportunity that the commission created in our recent rules amendments to allow for dispensing to occur via delivery Georgia.” The effort “addresses a legitimate need that a lot of people can clearly see,” he said. The companies said that while the new effort is Georgia-focused, it has implications that “may extend well beyond the state’s borders.” “By combining regulated medical cannabis operations with modern e-commerce infrastructure and authorized shipping, Botanical Sciences and Edibles.com are helping establish a model that other states may consider as they evaluate ways to improve patient access,” their press release says. A USPS official, when contacted by Marijuana Moment in August, declined to clearly state the agency’s position on participating in medical marijuana deliveries. Nikolaj Hagen, a senior public relations representative for USPS, pointed to general regulations on the mailability of controlled substances. Those rules state that if distribution of a controlled substance is unlawful, “then the mailing of the substance is also unlawful.” Mailing of controlled substances in domestic mail, they say, is only acceptable under three conditions—perhaps the most applicable of which allows shipping of prescription medications “when mailed by drug manufacturers or their registered agents, pharmacies, medical practitioners, or other authorized dispensers, as permitted by 21 CFR § 1307.11, or in compliance with any regulation of the FDA or other applicable law.” While state medical marijuana laws have allowed patients to access it via doctors’ recommendations, and not the formal prescription process due to federal prohibition, the cannabis rescheduling order that Attorney General Todd Blanche issued in April contains a provision that seems to deem those recommendations as prescriptions for the purposes of federal law: “Prescriptions. Notwithstanding part 1306 of this chapter or any other provision of these rules, a certification or other document (including an electronic document) that state law deems sufficient for a user to obtain marijuana or products containing marijuana for medical purposes shall be sufficient to permit dispensing of marijuana or products containing marijuana to a user so long as the certification or other document is dated as of, and signed on, the day when issued; bears the full name and address of the user; and contains the name, address, and state license number of the practitioner who signed the certification or other document and is authorized to do so under state law.” When pressed for further clarification on USPS’s position on mailing medical marijuana in light of rescheduling, Hagen simply said in August that “we have nothing additional to offer at this time.” He did not immediately reply to a new query from Marijuana Moment about the Botanical Sciences and Edibles.com effort on Tuesday. The post Georgia Companies Launch Medical Marijuana Delivery Via USPS Certified Mail As Federal Agency Refuses To Clarify Stance appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
Marijuana Moment: Veterans Groups Push Congress To Regulate Hemp THC Products Instead Of Banning Them
Tokeativity posted a topic in Marijuana Moment
A coalition of organizations representing military veterans is pushing Congress to call off a currently scheduled federal ban on hemp THC products that’s set to take effect next month and replace it with a policy that keeps them legally available with new regulations. “We share the goals that drove the current law: keeping intoxicating products away from children and ending an unregulated market,” the groups, including Veterans of Foreign Wars (VFW), wrote in a letter to House and Senate leaders on Tuesday. “A blanket ban does not achieve either. It would close compliant businesses, many of them owned or staffed by veterans, and push consumers toward unregulated sources with no testing, labeling, or age checks.” Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that redefined hemp to make it so only products with 0.4 milligrams of total THC per container would remain legal after November 12. Under provisions included in a separate funding bill Trump signed this September, however, the effective date of the ban for most products was pushed back to December 11 to give lawmakers more time to craft regulations for hemp derivatives. There was a carve-out, however, to allow the recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” The veterans groups’ new letter says that “a federal framework can do what a ban cannot.” They are asking lawmakers to institute regulations including a minimum purchase age of 21, mandatory third-party testing and accurate labeling, child-resistant packaging with clear serving limits, oversight by a federal regulatory agency and legal protection for businesses that comply with the rules. In addition to VFW, the letter was signed by the Non Commissioned Officers Association, National American Indian Veterans, Burn Pits 360 and Grunt Style Foundation, among others. “Veterans have sacrificed for our country, and they deserve safe, responsible options for managing chronic pain, PTSD, anxiety, sleep problems, and other health conditions,” they wrote. “Many veterans, working with their healthcare providers, rely on hemp products as an alternative to opioids. If Congress fails to act, the products they depend on will suddenly become illegal, forcing them to turn to an unregulated market or go without.” “Our veterans deserve better,” the letter says. “Veterans know what it means to serve under clear rules, and we expect the same from the policies that govern products sold in our communities. We ask Congress to act before the current deadline, with a framework that protects consumers and preserves lawful commerce.” Last year, VFW entered into a partnership with Torch Drinks, a hemp THC beverage company that involved a licensing branding deal aimed at supporting veterans services and promoting cannabis drinks as a potential alcohol alternative. The agreement involved making the cannabis drinks available at VFW posts across the country in jurisdictions where they are legal. Meanwhile, a top GOP congressman is pushing to attach provisions to keep hemp products legal to larger spending legislation in the coming weeks. “The best opportunity, in my opinion, is to get this on a bill that is going to pass,” Rep. James Comer (R-KY), who chair the House Oversight and Government Reform Committee, said. “The only bill that I think that absolutely, positively has to pass is going to be another continuing resolution, which is what got us here to begin with.” Read the veterans’ hemp letter to Congress below: The post Veterans Groups Push Congress To Regulate Hemp THC Products Instead Of Banning Them appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net -
A key Republican lawmaker is floating the idea of keeping hemp THC products federally legal by attaching language to a must-pass spending bill. “The best opportunity, in my opinion, is to get this on a bill that is going to pass,” Rep. James Comer (R-KY), who chair the House Oversight and Government Reform Committee, told Spectrum News 1. “The only bill that I think that absolutely, positively has to pass is going to be another continuing resolution, which is what got us here to begin with,” he said, referring to legislation to extend funding for federal agencies past the current December 11 expiration date. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that redefined hemp to make it so only products with 0.4 milligrams of total THC per container would remain legal after November 12. Under provisions included in a separate funding bill Trump signed this September, however, the effective date of the ban for most products was pushed back to December 11 to give lawmakers more time to craft regulations for hemp derivatives. There was a carve-out, however, to allow the recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” Industry advocates have warned that unless Congress is able to find a way to further delay or reverse the planned broader recriminalization of hemp THC products, many operators in the market will go out of business. Comer said he has “farmer friends that are planning on growing hemp next year.” “We’ve got tons of labs in the state, people that have made significant investments and it just makes me so mad because the industry is working, and it’s a huge success story,” he said. Rep. Morgan Griffith (R-VA) similarly recently floated the idea of including hemp extension and regulation language in a broader budget reconciliation bill. The Congressional Research Service noted in a recent report that the Food and Drug Administration (FDA) is now more than nine months late in fulfilling a legal mandate to publish a list of known cannabinoids and guidance on hemp product containers that was included in last year’s hemp product recriminalization legislation. A number of lawmakers from both chambers and both parties have filed or are circulating a growing number of bills to prevent the scheduled federal recriminalization of hemp THC drinks and other products. Comer, for example, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. Reps. Beth Van Duyne (R-TX) and Greg Landsman (D-OH) introduced a bill to keep hemp THC drinks legal while taxing and regulating them like alcohol. Separately, Rep. Andy Barr (R-KY), filed a lengthier proposal to prevent the federal recriminalization of hemp THC products and put in place a number of regulations for manufacturing, labeling, sales and taxation of hemp-derived products, including an age limit of 21. Griffith and Rep. Marc Veasey (D-TX) introduced a measure to allow continued sales of hemp THC products to adults over 21, with new regulations, Several Republican lawmakers recently spoke to Marijuana Moment about the kinds of rules they would like to see enacted to keep hemp THC products legal. Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN) are expected to soon file a hemp product regulation proposal that advocates hope to attach to broader, must-pass legislation by December 11. The post The Best Chance To Keep Hemp THC Products Legal Is By Attaching Provisions To A Larger Bill, GOP Congressman Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net
-
Marijuana Moment: Schumer vs. Van Hollen on cannabis (Newsletter: November 17, 2026)
Tokeativity posted a topic in Marijuana Moment
WI will “definitely” legalize; Top PA senator: Marijuana not a priority; VA cannabis law tweaks; State officials org on DEA rescheduling confusion Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Marijuana Moment compiled a comprehensive look at where Senate Minority Leader Chuck Schumer (D-NY) and Sen. Chris Van Hollen (D-MD) stand on cannabis as they compete to be elected Senate majority leader for the 120th Congress. Both support federally legalizing marijuana but have placed differing emphasis on the issue—with Schumer actually filing bills to enact the policy change and Van Hollen consistently voting in favor of reform when other lawmakers have proposed legislation. Wisconsin’s incoming Senate majority leader said Democrats will “definitely” legalize marijuana during their first year in control of the legislature—and the top Republican senator indicated he’s open to discussing cannabis reform, but said he has “got to see the bill” first. Pennsylvania’s Democratic incoming Senate president pro tempore said legalizing marijuana is “not maybe necessarily one of the high priority items that we feel like we’ve been given a clear responsibility to address” in 2027—adding that cannabis is “something we will talk about in the coming months—but not necessarily right away.” The Virginia legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market voted to approve recommended changes to the state’s marijuana legalization law—including reduced fines for public consumption and enacting a ban on lawmakers having an ownership stake in the legal industry. Kentucky Gov. Andy Beshear (D) is calling on Congress to pass a marijuana banking bill—saying it would benefit his state’s medical cannabis program and is “important because it would help increase public safety, increase revenues, help our economy and improve transparency.” The Cannabis Regulators Association’s Gillian Schauer—who represents state officials across the U.S.—argues in a new Marijuana Moment op-ed that the Drug Enforcement Administration’s recent cannabis rescheduling implementation actions “have created deep uncertainty and disruption for regulators, patients and market operators” and came with “little or no advance notice to state regulators and minimal communication afterward.” “Supply chains in many states will not have enough cultivators, manufacturers and dispensaries to support a viable supply chain in either the DEA market or the state-only market… With bifurcated and incomplete supply chains in states, some businesses will not survive in either market, patient access will be impacted, diversion and inversion will become more difficult for regulators to detect, health and safety compliance will be eroded and state revenues that support a variety of public services will decrease.” The Nebraska Medical Cannabis Commission advanced rules for the industry without making changes to provisions on testing and fees that were requested by all four of the state’s licensed cultivation businesses. / FEDERAL The National Highway Traffic Safety Administration is seeking White House Office of Management and Budget approval to conduct a survey evaluating impaired driving public education campaigns, including updating a questionnaire to “focus on not just alcohol-impaired driving, but drug-impaired, specifically cannabis, driving as well as it was not evaluated in previous surveys.” Former Pardon Attorney Ed Martin said there are “kids on marijuana all over this country that are being devastated by it.” Sen. Amy Klobuchar (D-MN) tweeted, “A federal ban on hemp products would be devastating for small businesses and jobs in Minnesota and across the country. I am fighting for a bipartisan fix to protect our state’s hemp industry.” / STATES Oklahoma Gov. Kevin Stitt (R) cited the example of a resident of his state who was deported over a marijuana charge that was expunged under state law as a federal immigration policy that doesn’t “make common sense.” Former New Jersey Gov. Chris Christie (R) discussed his opposition to legalizing marijuana but said “medical use for the appropriate conditions” is “the right thing to do.” Virginia’s Senate president pro tempore pleaded not guilty to federal corruption and marijuana-related charges. A Pennsylvania Republican representative said revenue from marijuana legalization “doesn’t account for the societal problems that that introduces as well, and the increase to human services and the rest of the fallout.” Colorado regulators issued an alert about marijuana products from a business that was burgled. California regulators are proposing to eliminate marijuana from random drug testing for certain correctional workers. Rhode Island regulators filed proposed changes to rules on marijuana business operational requirements. Maryland regulators published guidance about changes to hemp product laws. Pennsylvania’s Independent Fiscal Office noted that revenue projections for marijuana legalization are speculative. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL A Mexican senator is proposing to revive discussions about marijuana legalization. / SCIENCE & HEALTH A study found that “terpenes and cannabinoids modulate pain signalling in nociceptive neurons via distinct pathways.” A study suggested that full-spectrum cannabidiol-rich extract “pre-treatment may have chemopreventive potential against UVB-induced skin carcinogenesis.” / ADVOCACY, OPINION & ANALYSIS The Marijuana Policy Project has a new policy director and general counsel. / BUSINESS Charlotte’s Web Holdings, Inc. reported quarterly revenue of $9.4 million and a net loss of $3.5 million—saying it has generated “no revenue” so far from a federal plan to cover hemp CBD products under Medicare, and “does not anticipate meaningful” revenue related to the effort this year. Boots announced it will begin prescribing medical cannabis in the UK. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Schumer vs. Van Hollen on cannabis (Newsletter: November 17, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net -
Jennyarora started following Tokeativity Social: Harvest Moon
-
Quiet nights can turn intimate quickly. Being with Female Delhi Call Girl brought a slow build of chemistry and physical closeness. Nothing felt performative. Soft moments mixed with stronger desire and the evening stayed centered on mutual comfort.
-
moniouspea started following Eyes Wide Love: Tokeativity Back to the 90’s
-
Eyes Wide Love: Tokeativity Back to the 90’s
moniouspea commented on Lisa's blog entry in Tokeativity HQ Blog
Slope offers endless rolling action with a strong focus on timing and reflexes. Players guide a fast-moving ball across floating tracks while avoiding obstacles, gaps, and dangerous edges.
